ICC International Cannabis Competitors

ICC International Cannabis (OTCMKTS:KNHBF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

Profitability

This table compares ICC International Cannabis and Abacus Health Products' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations and price targets for ICC International Cannabis and Abacus Health Products, as reported by MarketBeat.com.

Earnings and Valuation

This table compares ICC International Cannabis and Abacus Health Products' revenue, earnings per share (EPS) and valuation.

ICC International Cannabis (OTCMKTS:KNHBF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Valuation & Earnings

This table compares ICC International Cannabis and Acreage's top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current ratings and price targets for ICC International Cannabis and Acreage, as provided by MarketBeat.com.

Acreage has a consensus target price of $8.4333, indicating a potential upside of 204.45%.

Profitability

This table compares ICC International Cannabis and Acreage's net margins, return on equity and return on assets.

Summary

Acreage beats ICC International Cannabis on 1 of the 1 factors compared between the two stocks.

ICC International Cannabis (OTCMKTS:KNHBF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares ICC International Cannabis and Applied Biosciences' gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for ICC International Cannabis and Applied Biosciences, as provided by MarketBeat.com.

Profitability

This table compares ICC International Cannabis and Applied Biosciences' net margins, return on equity and return on assets.

ICC International Cannabis (OTCMKTS:KNHBF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

Earnings and Valuation

This table compares ICC International Cannabis and Ayr Strategies' top-line revenue, earnings per share and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for ICC International Cannabis and Ayr Strategies, as reported by MarketBeat.

Ayr Strategies has a consensus price target of $34.8571, suggesting a potential upside of 63.96%.

Profitability

This table compares ICC International Cannabis and Ayr Strategies' net margins, return on equity and return on assets.

Summary

Ayr Strategies beats ICC International Cannabis on 1 of the 1 factors compared between the two stocks.

Can B (NASDAQ:CANB) and ICC International Cannabis (OTCMKTS:KNHBF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.

Profitability

This table compares Can B and ICC International Cannabis' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Can B and ICC International Cannabis' gross revenue, earnings per share and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Can B and ICC International Cannabis, as reported by MarketBeat.

ICC International Cannabis (OTCMKTS:KNHBF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Earnings & Valuation

This table compares ICC International Cannabis and Cansortium's top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of current recommendations for ICC International Cannabis and Cansortium, as provided by MarketBeat.

Cansortium has a consensus target price of $1.20, suggesting a potential upside of 39.67%.

Profitability

This table compares ICC International Cannabis and Cansortium's net margins, return on equity and return on assets.

Summary

Cansortium beats ICC International Cannabis on 1 of the 1 factors compared between the two stocks.